Strides completes acquisition of Genepharm
This article was originally published in Scrip
Executive Summary
Strides Arcolab has completed the acquisition of a controlling interest in Genepharm Australasia (now renamed Ascent Pharmahealth), becoming the fourth largest generic company in Australia.